Clinical Trial Update: Switch From Etravirine to Doravirine as a Part of Antiretroviral Combination

View source ↗

Summary

This trial update reports the completion of a study evaluating switching from Etravirine to Doravirine as part of an antiretroviral regimen for HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Intelence (Etravirine)
• PIFELTRO (doravirine)

Snippet

Sponsor: Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | Conditions: HIV Infections | Status: COMPLETED